| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.57B | 1.55B | 1.49B | 1.63B | 1.54B |
| Gross Profit | 342.84M | 383.96M | 366.73M | 352.13M | 316.85M |
| EBITDA | 199.25M | 220.01M | 218.50M | 192.62M | 160.62M |
| Net Income | 138.19M | 171.05M | 141.07M | 118.03M | 89.69M |
Balance Sheet | |||||
| Total Assets | 1.44B | 1.42B | 1.36B | 1.26B | 1.30B |
| Cash, Cash Equivalents and Short-Term Investments | 373.24M | 423.55M | 294.48M | 213.65M | 135.69M |
| Total Debt | 16.33M | 12.00M | 15.24M | 22.17M | 29.00M |
| Total Liabilities | 329.57M | 305.83M | 292.24M | 242.13M | 281.49M |
| Stockholders Equity | 1.10B | 1.10B | 1.05B | 998.86M | 998.60M |
Cash Flow | |||||
| Free Cash Flow | 115.97M | 197.09M | 161.51M | 182.14M | 64.55M |
| Operating Cash Flow | 207.31M | 264.07M | 229.15M | 240.08M | 120.26M |
| Investing Cash Flow | -95.25M | -31.35M | -56.57M | -53.77M | -71.35M |
| Financing Cash Flow | -155.95M | -102.64M | -90.79M | -106.41M | -22.62M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | HK$13.98B | 8.83 | 12.93% | 5.22% | 14.63% | 15.55% | |
74 Outperform | HK$12.35B | 11.59 | 9.07% | 10.16% | -0.14% | -14.24% | |
74 Outperform | HK$24.62B | 8.62 | 9.61% | 7.69% | 5.75% | 0.93% | |
73 Outperform | HK$469.92M | 1.91 | 27.89% | 5.45% | 31.25% | 147.52% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$471.72M | 8.99 | -10.55% | 11.54% | -1.38% | -275.02% | |
49 Neutral | HK$298.07M | -12.78 | -2.53% | 4.15% | 2.32% | -88.07% |